Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study

Fig. 3

Overall survival analyses according to treatment group in matched patients after propensity score matching. The plots showed significant survival benefit of whole brain radiation therapy plus focal radiation boost (WBRT+boost) in 140 matched patients, compared to whole-brain radiation therapy (WBRT) alone (17.9 vs 11.7 months; P = 0.045; Fig. 3a). WBRT+boost group also resulted in significant survival advantage over stereotactic radiosurgery (SRS) groups among 140 matched patients (21.8 vs 12.9 months; P = 0.040; Fig. 3b)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us